Literature DB >> 9018119

Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells.

K Takenaga1, Y Nakamura, S Sakiyama.   

Abstract

S100A4 (also known as pEL98/mts1/p9Ka/18A2/42A/calvasculin /FSP1/CAPL), a member of S100-related calcium-binding proteins, has been implicated to play a role in metastasis. In the present study, we examined the effect of antisense S100A4 RNA on metastatic potential of Lewis lung carcinoma (LLC) cells. High-metastatic All cells were transfected with the expression vector containing S100A4 cDNA in an inverted (antisense) orientation under the transcriptional control of the mouse metallothionein promoter. Treatment of a stably transfected clone (AS10 cells) with Zn2+ resulted in the suppression of the experimental metastatic ability, which was accompanied with the expression of antisense S100A4 RNA and the suppression of the S100A4 expression at both the mRNA and the protein levels. To further confirm the effect of antisense S100A4 RNA, we established several clones after retroviral transduction with an antisense S100A4 construct. Notably, reduced metastatic potential was also evident in these clones. In the antisense S100A4 RNA-expressing cells, cell motility and in vitro invasiveness were found to be suppressed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9018119     DOI: 10.1038/sj.onc.1200820

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

1.  Resistance to apoptosis induced by microenvironmental stresses is correlated with metastatic potential in Lewis lung carcinoma.

Authors:  M Takasu; Y Tada; J O Wang; M Tagawa; K Takenaga
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines.

Authors:  N Nakamura; K Takenaga
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

3.  Protein S100A4: too long overlooked by pathologists?

Authors:  Luca Mazzucchelli
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

4.  Introduction of an N-terminal peptide of S100C/A11 into human cells induces apoptotic cell death.

Authors:  Eiichi Makino; Masakiyo Sakaguchi; Keiji Iwatsuki; Nam-ho Huh
Journal:  J Mol Med (Berl)       Date:  2004-07-06       Impact factor: 4.599

5.  S100A4 downregulates filopodia formation through increased dynamic instability.

Authors:  Connie Goh Then Sin; Nils Hersch; Philip S Rudland; Roger Barraclough; Bernd Hoffmann; Stephane R Gross
Journal:  Cell Adh Migr       Date:  2011 Sep-Oct       Impact factor: 3.405

Review 6.  The heavy chain has its day: regulation of myosin-II assembly.

Authors:  Natalya G Dulyaninova; Anne R Bresnick
Journal:  Bioarchitecture       Date:  2013 Jul-Aug

Review 7.  S100A4 and metastasis: a small actor playing many roles.

Authors:  Kjetil Boye; Gunhild M Maelandsmo
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

8.  Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells.

Authors:  Nick Devoogdt; Gholamreza Hassanzadeh Ghassabeh; Jing Zhang; Lea Brys; Patrick De Baetselier; Hilde Revets
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

9.  A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics.

Authors:  Sarah C Garrett; Louis Hodgson; Andrew Rybin; Alexei Toutchkine; Klaus M Hahn; David S Lawrence; Anne R Bresnick
Journal:  Biochemistry       Date:  2007-12-23       Impact factor: 3.162

10.  Overexpression of S100A4 in human cancer cell lines resistant to methotrexate.

Authors:  Nuria Mencía; Elisabet Selga; Isabel Rico; M Cristina de Almagro; Xenia Villalobos; Sara Ramirez; Jaume Adan; Jose L Hernández; Véronique Noé; Carlos J Ciudad
Journal:  BMC Cancer       Date:  2010-06-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.